Indeed, recent work24,25 has focused on these twin hotspots mutations in PLEKHS1 and ADGRG6 (also called GPR126) as potential drivers or biomarkers of bladder cancer. The gene discussed is ADGRG6; the disease is urinary bladder carcinoma.